The identification of ETAR in endothelial cells of patients with FSGS and its involvement in podocyte−endothelial crosstalk would shed light onto a potential new mechanism of action of the endothelin system in the development of human FSGS. This evidence concerns the gene EDNRA and focal segmental glomerulosclerosis.